Insider Cluster (4 insiders) ·Filed Mar 3, 2026

BLFS

BIOLIFE SOLUTIONS INC
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $12K total
Actionable Insight • Neutral

Monitor for additional insider selling in the next 30 days — if volume increases significantly, it could signal growing concern. For now, this cluster is within normal range and not a trading catalyst.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
BLFS ▲ +21.47% at T+60d
NEUTRAL call ✓ call won +21.47% · α vs SPY +11.15% · entry $20.17 → $24.50
Entry anchored
Mar 2, 03:59 PM ET
via exchange tick
T+1d
+2.48%
call +2.48% · α +1.72%
$20.67
settled 7mo ago
T+5d
-7.44%
call -7.44% · α -6.96%
$18.67
settled 7mo ago
T+20d
-5.40%
call -5.40% · α -1.00%
$19.08
settled 6mo ago
T+60d
+21.47%
call +21.47% · α +11.15%
$24.50
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Four C-suite executives at BioLife Solutions — including the CFO and Chief Quality and Operations Officer — sold shares in a coordinated open-market transaction on March 3, 2026, totaling $32,728 in value. The sales were small in absolute size and represent a negligible fraction of the company's $998M market cap. This appears to be routine portfolio management rather than a signal of material concern.

Key Financial Metrics

Direction
selling
Total Value
$32.7K
Insiders
4

Key Facts

  • Four C-suite executives sold shares on the same day (March 3, 2026) in open-market transactions.
  • Total value of sales: $32,728 (aggregated across CFO, Chief Quality and Operations, Chief HR Officer, and Chief Marketing Officer).
  • All transactions were coded as 'S' (open-market sale) at $20.74 per share.
  • Total insider sales over the past 30 days amount to $33K, consistent with recent patterns.

Financial Impact

$32,728 in total insider sales, representing 0.0033% of market cap

insider ownershipmarket sentiment

Risk Factors

  • Perception risk: Multiple C-suite sales on the same day may attract speculative attention despite small size.
  • Lack of offsetting insider buying — no purchases in this cluster or recent history.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-BLFS-1772748656000
5 reports for BLFS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BLFS — sortable, filterable
TypeNow
Sep 4, 2026
27d ago
DEFM14A
BULLISH ★ 7/10
$35.38 $36.39▲ +2.85%▲ +3.97%$37.30 (+5.43%)
Jun 3, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$27.25 $26.66▼ −2.17%▲ +1.65%$37.30 (+36.88%)
Apr 28, 2026
22w ago
10-K/A
NEUTRAL ★ 2/10
$19.99 $21.75▲ +8.80%▲ +5.69%$37.30 (+86.59%)
Mar 3, 2026
30w ago
Insider Cluster
BEARISH ★ 6/10
$20.17 $18.67▲ +7.44%▲ +6.96%$37.30 (−84.93%)
Mar 3, 2026
30w ago
Insider Cluster
NEUTRAL ★ 3/10
$20.17 $18.67▼ −7.44%▼ −6.96%$37.30 (+84.93%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (65h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 5, 2026